UNH vs BMY
By Alex · Tickerpine
UnitedHealth Group Incorporated vs Bristol-Myers Squibb Company, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | UNH | BMY |
|---|---|---|
| Price | $396.59 | $67.92 |
| Market cap | $355.98B | $138.74B |
| P/E ratio | 25.6 | 15.0 |
| ROE | 14.15% | 46.60% |
| Profit margin | 3.14% | 18.87% |
| Revenue growth | 0.40% | 5.70% |
| Dividend yield | 2.33% | 3.75% |
| Beta | 0.63 | 0.23 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
UNH vs BMY in plain English
- UNH is the bigger company — about 2.6× the market cap of BMY.
- BMY is cheaper on earnings (P/E 15.0 vs 25.6).
- BMY earns a higher return on equity (47% vs 14%).
- BMY is growing revenue faster (6% vs 0%).
- BMY has the higher dividend yield (3.75% vs 2.33%).
How would $1,000 have done in each?
UNH return calculator
See what $1,000 in UnitedHealth Group Incorporated would be worth today.
BMY return calculator
See what $1,000 in Bristol-Myers Squibb Company would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.